106 related articles for article (PubMed ID: 35969108)
1. Live Imaging of Microtubule Dynamics in Glioblastoma Cells Invading the Zebrafish Brain.
Peglion F; Coumailleau F; Etienne-Manneville S
J Vis Exp; 2022 Jul; (185):. PubMed ID: 35969108
[TBL] [Abstract][Full Text] [Related]
2. Quantification of glioblastoma progression in zebrafish xenografts: Adhesion to laminin alpha 5 promotes glioblastoma microtumor formation and inhibits cell invasion.
Gamble JT; Reed-Harris Y; Barton CL; La Du J; Tanguay R; Greenwood JA
Biochem Biophys Res Commun; 2018 Dec; 506(4):833-839. PubMed ID: 30389143
[TBL] [Abstract][Full Text] [Related]
3. An orthotopic glioblastoma animal model suitable for high-throughput screenings.
Pudelko L; Edwards S; Balan M; Nyqvist D; Al-Saadi J; Dittmer J; Almlöf I; Helleday T; Bräutigam L
Neuro Oncol; 2018 Oct; 20(11):1475-1484. PubMed ID: 29750281
[TBL] [Abstract][Full Text] [Related]
4. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma research on zebrafish xenograft models: a systematic review.
Pliakopanou A; Antonopoulos I; Darzenta N; Serifi I; Simos YV; Katsenos AP; Bellos S; Alexiou GA; Kyritsis AP; Leonardos I; Vezyraki P; Peschos D; Tsamis KI
Clin Transl Oncol; 2024 Feb; 26(2):311-325. PubMed ID: 37400666
[TBL] [Abstract][Full Text] [Related]
6. Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts.
Almstedt E; Rosén E; Gloger M; Stockgard R; Hekmati N; Koltowska K; Krona C; Nelander S
Neuro Oncol; 2022 May; 24(5):726-738. PubMed ID: 34919147
[TBL] [Abstract][Full Text] [Related]
7. Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway.
Zhu M; Niu J; Jiang J; Dong T; Chen Y; Yang X; Liu P
Life Sci; 2022 Mar; 293():120358. PubMed ID: 35092731
[TBL] [Abstract][Full Text] [Related]
8. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.
Radaelli E; Ceruti R; Patton V; Russo M; Degrassi A; Croci V; Caprera F; Stortini G; Scanziani E; Pesenti E; Alzani R
Histol Histopathol; 2009 Jul; 24(7):879-91. PubMed ID: 19475534
[TBL] [Abstract][Full Text] [Related]
9. Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish.
Ai X; Ye Z; Xiao C; Zhong J; Lancman JJ; Chen X; Pan X; Yang Y; Zhou L; Wang X; Shi H; Zhang D; Yao Y; Cao D; Zhao C
Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35199829
[TBL] [Abstract][Full Text] [Related]
10. ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme.
Cherry AE; Haas BR; Naydenov AV; Fung S; Xu C; Swinney K; Wagenbach M; Freeling J; Canton DA; Coy J; Horne EA; Rickman B; Vicente JJ; Scott JD; Ho RJ; Liggitt D; Wordeman L; Stella N
Mol Cancer Ther; 2016 Sep; 15(9):2018-29. PubMed ID: 27325686
[TBL] [Abstract][Full Text] [Related]
11. Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model.
Alberti G; Amico MD; Caruso Bavisotto C; Rappa F; Marino Gammazza A; Bucchieri F; Cappello F; Scalia F; Szychlinska MA
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791432
[TBL] [Abstract][Full Text] [Related]
12. Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma.
Finotto L; Cole B; Giese W; Baumann E; Claeys A; Vanmechelen M; Decraene B; Derweduwe M; Dubroja Lakic N; Shankar G; Nagathihalli Kantharaju M; Albrecht JP; Geudens I; Stanchi F; Ligon KL; Boeckx B; Lambrechts D; Harrington K; Van Den Bosch L; De Vleeschouwer S; De Smet F; Gerhardt H
EMBO Mol Med; 2023 Nov; 15(11):e18144. PubMed ID: 37791581
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-377 inhibited proliferation and invasion of human glioblastoma cells by directly targeting specificity protein 1.
Zhang R; Luo H; Wang S; Chen W; Chen Z; Wang HW; Chen Y; Yang J; Zhang X; Wu W; Zhang SY; Shen S; Dong Q; Zhang Y; Jiang T; Lu D; Zhao S; You Y; Liu N; Wang H
Neuro Oncol; 2014 Nov; 16(11):1510-22. PubMed ID: 24951112
[TBL] [Abstract][Full Text] [Related]
14. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.
Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA
Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508
[TBL] [Abstract][Full Text] [Related]
15. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.
Eskilsson E; Rosland GV; Talasila KM; Knappskog S; Keunen O; Sottoriva A; Foerster S; Solecki G; Taxt T; Jirik R; Fritah S; Harter PN; Välk K; Al Hossain J; Joseph JV; Jahedi R; Saed HS; Piccirillo SG; Spiteri I; Leiss L; Euskirchen P; Graziani G; Daubon T; Lund-Johansen M; Enger PØ; Winkler F; Ritter CA; Niclou SP; Watts C; Bjerkvig R; Miletic H
Neuro Oncol; 2016 Dec; 18(12):1644-1655. PubMed ID: 27286795
[TBL] [Abstract][Full Text] [Related]
16. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
[TBL] [Abstract][Full Text] [Related]
17. Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity.
Welker AM; Jaros BD; Puduvalli VK; Imitola J; Kaur B; Beattie CE
Dis Model Mech; 2016 Feb; 9(2):199-210. PubMed ID: 26659251
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
19. IL13RA2 targeted alpha particle therapy against glioblastomas.
Sattiraju A; Solingapuram Sai KK; Xuan A; Pandya DN; Almaguel FG; Wadas TJ; Herpai DM; Debinski W; Mintz A
Oncotarget; 2017 Jun; 8(26):42997-43007. PubMed ID: 28562337
[TBL] [Abstract][Full Text] [Related]
20. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
D'Alessandro G; Catalano M; Sciaccaluga M; Chece G; Cipriani R; Rosito M; Grimaldi A; Lauro C; Cantore G; Santoro A; Fioretti B; Franciolini F; Wulff H; Limatola C
Cell Death Dis; 2013 Aug; 4(8):e773. PubMed ID: 23949222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
